Barely Significant
← all excerpts

Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.

J Natl Cancer Inst · 2013 · PMC3888138 · PMID 23812955

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

marginally statistically significantP = .05actually significant
H/I status remained marginally statistically significant in the adjusted model (OR = 2.15; 95% CI = 1.00 to 4.64; P = .05) after adjusting for all clinicopathological factors examined (age, tumor size, tumor grade, nodal status, ER, PR, HER2) ( Supplementary Table 2 ).

also in 1,110 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.